Medical Systems Virology group at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki, together with its national and international collaborators, developed a new cell screening method that can be used to identify potential anti-influenza drugs. The researchers were able to identify two novel compounds with anti-influenza activity, obatoclax and gemcitabine and prove the efficacy of a previously known drug saliphenylhalamide. The study was recently accepted for publication in the Journal of Biological Chemistry and is now available online.
Click "source" to read more.
(http://savotta.helsinki.fi/halvi/tiedotus/lehti.nsf/e1e392ad852e72f5c225680000404fa8/7fe3c1c3a8f7160dc2257a70003e5b2e?OpenDocument)
